18 results about "BUTTON MUSHROOM EXTRACT" patented technology

A composition for making a drink includes a coffee bean ingredient, an antacid ingredient, a polysaccharide ingredient having an extract from mushroom, and solid particles including the coffee bean ingredient, the antacid ingredient and the polysaccharide ingredient. The composition includes the coffee bean ingredient from 80 wt-% to 99 wt-% based on a total weight of the composition, the antacid ingredient from 0.5 wt-% to 10 wt-% based on the total weight of the composition, and the polysaccharide ingredient from 0.5 wt-% to 10 wt-% based on the total weight of the composition.

The application discloses a composition with long-acting anti-wrinkle, skin elasticity improvement and skin tightening effects, a preparation method and application thereof, and belongs to the technical field of cosmetics. The composition comprises the following efficacy components: Schizosaccharomyces pombe ferment lysate, hydroxypropyl tetrahydropyrane triol, lactose, whey protein, lactic acid, Lactarius volemus extract and palm leaf tree extract. The eye cream prepared by using the composition has very significant long-acting anti-wrinkle, skin elasticity improvement and skin tightening effects. After 28 days of use, the R2 value of skin elasticity at the corner of the eye is increased by more than 20%, the R0 value of total skin stretching displacement is decreased by more than 40%, the proportion of wrinkle area is decreased by more than 15%, and the wrinkle depth is decreased by more than 27%. The effect after 28 days of use is also significantly better than that after 14 days of use.

The present invention addresses the problem of providing a technique capable of imparting a good egg flavor to food (in particular, emulsified food).　The present invention provides an emulsified food comprising: 0.05 mass% to 2.00 mass% (in terms of solid content) of a mushroom extract; and 0.0010 mass% to 0.0150 mass% (in terms of free form) of sulfur, wherein the mushroom extract includes a shiitake mushroom extract and / or a button mushroom extract.

The present invention relates to a customizable injectable solution comprising Human Growth Hormone (HGH), Insulin-like Growth Factor 1 (IGF-1), or a growth hormone secretagogue such as sermorelin or ipamorelin, combined with a blend of nutrients including amino acids, vitamins, electrolytes, functional mushroom extracts, and optionally mushroom mycelium. The solution is delivered via a dual-chamber syringe to preserve component stability, with mixing occurring immediately before administration. The formulation is suitable for subcutaneous, intramuscular, or intravenous injection and may be tailored for muscle growth, cognitive performance, immune support, or neuroregeneration. The invention also contemplates injectable formulations of functional mushrooms alone, as well as alternative delivery methods such as sublingual troches containing GH-inducing peptides, functional mushrooms, and ketamine. This system provides a versatile, bioavailable, and clinically adaptable approach to personalized health optimization.

The invention discloses a method for preparing a flat mushroom extract. The invention uses flat mushroom and Candida lipolytica to prepare an extract rich in polypeptides and EGT, and the extract has significant antioxidant and free radical scavenging abilities, and can be used as a cosmetic raw material. The method comprises the following steps: activating flat mushroom and Candida lipolytica strains and then implanting them into a liquid culture medium to obtain seed liquid; inoculating the obtained seed liquid into a fermentation culture medium for fermentation; after the fermentation is completed, the fermentation liquid can be obtained after separation treatment. In the invention, the two strains are fermented together, which can exert a synergistic effect, not only making the EGT content reach 355.9 mg / L, but also significantly increasing the polypeptide yield to 4.93 g / L, and the DPPH and ABTS scavenging rates of the obtained flat mushroom extract after diluting 5 times are 93.7% and 80.4% respectively. It has significant antioxidant and free radical scavenging abilities.

The invention discloses an anti-hair-loss composition containing a cacumen biotae extract and a preparation method of the anti-hair-loss composition, and particularly belongs to the technical field of scalp care and raw material compounding. The anti-hair loss composition comprises the following components: 8-12 parts of a red ginseng extract, 8-12 parts of a Chinese arborvitae twig and leaf extract, 3-4 parts of a flat ground mushroom extract, 2-3 parts of a dendrobium officinale stem extract and 1-2 parts of lactobacillus / ginseng root fermentation product filtrate. The anti-alopecia composition provided by the invention has a remarkable effect of inhibiting the activity of 5alpha-reductase, can remarkably improve the alopecia phenomenon of mice, inhibits the generation of testosterone and dihydrotestosterone, and reduces the risk of androgen-derived alopecia.

To provide a retort food oil and fat composition that can preserve the desirable original flavor of retort food even when stored for a long period of time, and a retort food using the retort food oil and fat composition. [Solution] A retort food oil composition wherein the total oil composition contains 0.015 to 15% by weight of tocopherol, 0.0005 to 0.15% by weight of mushroom extract (dry weight), and the weight ratio of tocopherol to mushroom extract is 8 to 250.

The present invention provides: an emulsion-type cosmetic composition comprising an inonotus obliquus extract as a main component and a composite mushroom extract combined with an extract of at least one mushroom selected from the group consisting of an inonotus obliquus extract and Ganoderma lucidum as a liposome preparation; and a method for preparing the emulsion-type cosmetic composition. According to the present invention, the composition can be combined with a retinol compound and a combination of two hyaluronic acids of different molecular weights (mixed hyaluronic acid) and a linear oil component, such that a significant skin anti-aging or oxidation-inhibiting effect can be provided, and skin gloss can be reduced.

To provide: an oil and fat composition for baked goods with which it is possible to preserve the baked goods without losing a preferable flavor inherent in the baked goods even when the baked goods are preserved for a long term; and baked goods using the oil and fat composition for baked goods.SOLUTION: An oil and fat composition for baked goods contains extracts of mushrooms, tocopherol and / or vitamin C.SELECTED DRAWING: None

To identify an active ingredient in a mushroom extract having antifungal effect, and to provide a novel antifungal agent.SOLUTION: Provided is a norbornene derivative represented by the following formula (1) (where R1 represents H or OH, R2 represents H or a cyano group, and R3 represents CH3 or CHO), and an antifungal agent containing the norbornene derivative as an active ingredient.SELECTED DRAWING: None

The present invention discloses a method for the isolation and purification of amatoxins in poisonous mushrooms. The specific steps include: S1. Firstly, separating the mushroom extract containing amatoxins by high-speed counter-current chromatography; S2. Secondly, separating the product after the first separation by preparative liquid chromatography. The present invention uses HSCCC combined with Pre-HPLC to isolate and purify amatoxins in Amanita mushrooms, collects the target substances in groups, and finally conducts purity analysis and structural confirmation, thereby establishing a method for isolating and purifying four components, namely α-AMA, β-AMA, carboxy-tricholoro-phalloidin, and carboxy-dihydroxy-phalloidin, in Amanita mushrooms. This method is simple to operate, fast and efficient, with high purity, good reproducibility, and high sample recovery rate.

The present invention relates to a customizable injectable solution comprising Human Growth Hormone (HGH), Insulin-like Growth Factor 1 (IGF-1), or a growth hormone secretagogue such as sermorelin or ipamorelin, combined with a blend of nutrients including amino acids, vitamins, electrolytes, functional mushroom extracts, and optionally mushroom mycelium. The solution is delivered via a dual-chamber syringe to preserve component stability, with mixing occurring immediately before administration. The formulation is suitable for subcutaneous, intramuscular, or intravenous injection and may be tailored for muscle growth, cognitive performance, immune support, or neuroregeneration. The invention also contemplates injectable formulations of functional mushrooms alone, as well as alternative delivery methods such as sublingual troches containing GH-inducing peptides, functional mushrooms, and ketamine. This system provides a versatile, bioavailable, and clinically adaptable approach to personalized health optimization.

This invention discloses an anti-aging composition that synergistically enhances mitochondrial function using AKG-PQQ, relating to the field of anti-aging technology. The composition comprises AKG, disodium PQQ, button mushroom extract, and excipients. By combining AKG, disodium PQQ, button mushroom extract, and a single excipient, AKG, as 2-oxoglutarate, directly participates in mitochondrial energy metabolism in anhydrous crystalline form, providing core substrate support for mitochondrial function. Disodium PQQ promotes mitochondrial regeneration, ensuring mitochondrial structural renewal and physiological activity. The naturally occurring β-glucan and ergothioneine in the button mushroom extract form a synergistic effect, maintaining the normal physiological state of mitochondria from multiple dimensions. The single excipient only physically mixes with the active ingredients, avoiding interference from interactions between multiple excipients and ensuring the full effectiveness of each active ingredient.

The invention relates to the technical field of anti-inflammatory intestinal health oral liquid, and discloses an anti-inflammatory intestinal health oral liquid formula based on a yellow mushroom extract. Comprising the following raw materials: 3g of yellow mushroom extract (containing ergosterol), 1g of fructo-oligosaccharide, 2g of erythritol, 5g of cane sugar, 2g of xylitol, 0.2 g of pectin, 0.1 g of xanthan gum, 0.2 g of citric acid, 0.1 g of malic acid, 5ml of glycerol, 0.2 g of natural orange essence, 0.05 g of nisin, 0.05 g of vitamin C and 100ml of purified water. According to the anti-inflammatory intestinal health-care oral liquid formula based on the yellow mushroom extract, the oral liquid is orally taken for 9 days in an equivalent dose continuously in DSS induced UC mice, the colon length can be remarkably recovered, the spleen index is reduced, tissue inflammation lesion is relieved, and the anti-inflammatory intestinal health-care oral liquid formula has anti-inflammatory and health-care functions aiming at UC patients and people with sub-healthy intestinal functions, and has a good application prospect. And compared with the prior art, the active ingredients are clearer, and the stability and the taste are better.

The present disclosure provides for compositions combining Cannabinoid Fractions and Mushroom Extract Fractions for recreational and medicinal uses. The disclosed compositions are useful for treating symptoms of anxiety, stress, pain, and promoting sleep. The pharmaceutical compositions comprise particular cannabinoid ratios and terpene profiles.

Cosmetic composition for suppressing skin irritations comprising: - Water, - polyhydric alcohols, - emulsifiers, - a mushroom extract.

The purpose of the present invention is to provide a novel TRPA1 agonist. The present invention relates to a composition for activating TRPA1, comprising a mushroom extract or lanthionine. The composition can enhance appetite and food consumption and ameliorate decreased appetite.

A herbal oral composition having the properties for supporting and enhancing musculoskeletal health and processes for manufacturing the same from ingredients are disclosed comprising: a herbal concentrate having a first predetermined percentage (%) by weight, a herbal powder mixture having a second predetermined percentage (%) by weight, a mushroom extract ingredient having a third predetermined percentage (%) by weight, a collagen extract ingredient having a fourth percentage (%) by weight, a solution containing 4-allylpyrocatechol having a fifth percentage (%) by weight, and a plant-derived nanovesicles ingredient having a sixth percentage (%) by weight.